GlycoMimetics, Inc. (GLYC)

GlycoMimetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.01	0.01	0.08	1.16	10.16	0
Revenue Growth (YoY)	-86.67%	-86.67%	-93.53%	-88.59%	-	-
Gross Profit	0.01	0.01	0.08	1.16	10.16	0
Selling, General & Admin	18.78	19.21	19.09	17.12	16.74	14.36
Research & Development	20.68	20.07	28.39	47.49	44.93	47.03
Operating Expenses	39.46	39.29	47.48	64.61	61.67	61.39
Operating Income	-39.45	-39.28	-47.4	-63.45	-51.51	-61.39
Other Expense / Income	-2.17	-2.38	-0.71	-0.02	-0.48	-3.5
Pretax Income	-37.28	-36.9	-46.69	-63.43	-51.03	-57.89
Net Income	-37.28	-36.9	-46.69	-63.43	-51.03	-57.89
Shares Outstanding (Basic)	64	63	53	51	46	43
Shares Outstanding (Diluted)	64	63	53	51	46	43
Shares Change	6.81%	20.58%	2.10%	12.54%	5.70%	5.38%
EPS (Basic)	-0.58	-0.58	-0.89	-1.23	-1.12	-1.34
EPS (Diluted)	-0.58	-0.58	-0.89	-1.23	-1.12	-1.34
Free Cash Flow	-33.81	-34.9	-46.54	-57.5	-39.31	-52.13
Free Cash Flow Per Share	-0.53	-0.55	-0.89	-1.12	-0.86	-1.21
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-394493.02%	-392752.93%	-63204.43%	-5470.69%	-506.84%	-
Profit Margin	-372767.37%	-368994.20%	-62251.74%	-5468.98%	-502.09%	-
Free Cash Flow Margin	-338085.09%	-349012.97%	-62055.57%	-4958.28%	-386.80%	-
EBITDA	-36.35	-35.89	-45.66	-62.41	-50.08	-56.99
EBITDA Margin	-363459.65%	-358898.81%	-60875.53%	-5381.58%	-492.72%	-
Depreciation & Amortization	0.93	1.01	1.03	1.01	0.95	0.9
EBIT	-37.28	-36.9	-46.69	-63.43	-51.03	-57.89
EBIT Margin	-372767.37%	-368994.20%	-62251.74%	-5468.98%	-502.09%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).